A vial of research peptide travels a long way before it reaches an analytical lab. The molecule is first assembled chemically, one link at a time, then separated from the byproducts of that same synthesis. Both steps decide what a lab actually sees when it measures the purity of a finished batch.
Synthesis: how amino acids become a chain
A peptide is a chain of amino acids joined by peptide bonds. The standard way to build such a chain at scale is solid-phase peptide synthesis, or SPPS. Robert Bruce Merrifield described the method in 1963 using the synthesis of a tetrapeptide as a working example [1], and the discovery later earned him the Nobel Prize in Chemistry.
The principle is simple; the execution is not. The first amino acid is chemically anchored to an insoluble resin. The next amino acids are then attached one by one, in a defined order. Before each attachment, the side groups of the new amino acid and of the growing chain are shielded with temporary protecting groups so the reaction happens exactly where it should. The most common protection scheme today is called Fmoc; it replaced the older Boc scheme because its deprotection conditions are milder [2]. Once every link is in place, the finished chain is cleaved from the resin and the side groups are freed from their protecting groups.
Because the chain is built one link at a time, each coupling step has its own efficiency: usually high, but never total. For a short peptide of a few links, this barely registers. For a longer chain, the small error at each step adds up, and the reactor's output is not one pure molecule but a mixture. Most of it is the target peptide, alongside molecules missing a link, carrying an unremoved protecting group, or shaped by a side reaction at one of the steps.
Why a "crude" peptide is not ready for analysis yet
The mixture taken off the resin right after synthesis is called crude peptide in the industry. Besides the target molecule, it contains truncated sequences, often called deletion peptides, residues of protecting groups that did not fully come off, and compounds formed by side reactions during chain assembly. Most of these impurities are structurally close to the target peptide: the same amino acid sequence, missing or swapping just one or two links.
Something else is added to the crude material's weight that is not the peptide itself: a counter-ion left over from the synthesis chemistry. It is usually trifluoroacetic acid (TFA) or acetate, which is why the net content of the target peptide in a finished vial is almost always lower than the powder's total weight. A review of impurities in peptide products classifies these byproducts by origin and shows why more careful synthesis alone cannot remove them: some impurities are chemically too close to the target molecule and need a separate physical separation step once the reaction is already done [3].
Purification: separating the target molecule from impurities
This separation runs on preparative reversed-phase liquid chromatography, the same physical principle that analytical HPLC later uses to measure purity, only scaled to a real quantity of material rather than a microliter sample. The mixture is passed through a column packed with a hydrophobic sorbent and washed out with a solvent gradient of increasing strength. Molecules stick to the sorbent differently depending on their own hydrophobicity, so the target peptide and its closest structural relatives leave the column at slightly different times.
A classic study of preparative reversed-phase peptide chromatography, back in 1984, showed the method scales from microgram to multi-gram loads without a significant loss of separating power [4]. That property is what made it an industry standard for synthetic peptides rather than a laboratory curiosity. Fractions leaving the column are collected separately and checked; only the fraction where the target peak dominates moves on to analysis.
Separating closely related impurities is never perfect in a single chromatographic run. The purified material still needs to be measured: how much of the target substance survived the separation, and whether anything unwanted came along with it. That answer belongs to the analytical part of the process, not the preparative one.
What comes next
Synthesis and purification answer the question of how a peptide is made, not what exactly came out of it. Analytical HPLC and mass spectrometry answer that second question: HPLC measures the target peak's share among the rest, and mass spectrometry confirms the measured mass matches the one calculated for the intended sequence. Both methods are covered in detail in the guide to reading a peptide COA. A lab records these measurements as a document tied to one specific batch, and what that document does and does not confirm is explained in the article on what a certificate of analysis actually proves.
A short overview of peptide structure, molecule classes and the full path from synthesis to a certificate is on Tripept's "What peptides are" page.
Catalog and verification
See the catalog of research peptides. Batches are accompanied by certificates of analysis from independent third-party labs, published in the open COA archive.
This material is for reference only, describes how a research reagent is manufactured, and is not instructions for use.
Sources
- Merrifield RB. Solid Phase Peptide Synthesis. I. The Synthesis of a Tetrapeptide. Journal of the American Chemical Society, 1963. https://doi.org/10.1021/ja00897a025
- Behrendt R, White P, Offer J. Advances in Fmoc solid-phase peptide synthesis. Journal of Peptide Science, 2016. https://doi.org/10.1002/psc.2836
- D'Hondt M, Bracke N, Taevernier L, et al. Related impurities in peptide medicines. Journal of Pharmaceutical and Biomedical Analysis, 2014. https://doi.org/10.1016/j.jpba.2014.06.012
- Rivier J, McClintock R, Galyean R, Anderson H. Reversed-phase high-performance liquid chromatography: preparative purification of synthetic peptides. Journal of Chromatography A, 1984. https://doi.org/10.1016/S0021-9673(01)93709-4